BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2396117)

  • 1. [Several aspects of general biological concept of osteogenesis].
    Savitskaia KI; Onoprienko GA; Trapeznikova MF
    Sov Med; 1990; (6):13-8. PubMed ID: 2396117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early prognosis of the state of osteogenesis in bone lengthening].
    Giul'nazarova SV; Mamaev VI
    Ortop Travmatol Protez; 1989 Apr; (4):32-5. PubMed ID: 2740129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mineral metabolism of bones in osteomyelitis].
    Sveshnikov AA; Ofitserova NV; Kramer GM
    Patol Fiziol Eksp Ter; 1984; (4):63-5. PubMed ID: 6483483
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone repair using mineral trioxide aggregate combined to a material carrier, associated or not with calcium hydroxide in bone defects.
    do Nascimento C; Issa JP; Iyomasa MM; Regalo SC; Siéssere S; Pitol DL; de Oliveira Wolga N; Pedrazzi V
    Micron; 2008 Oct; 39(7):868-74. PubMed ID: 18242096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta].
    Tanaka H
    Clin Calcium; 2009 Aug; 19(8):1142-7. PubMed ID: 19638698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1.
    Duman O; Ozdem S; Turkkahraman D; Olgac ND; Gungor F; Haspolat S
    Brain Dev; 2008 Oct; 30(9):584-8. PubMed ID: 18362054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury.
    Maïmoun L; Couret I; Mariano-Goulart D; Dupuy AM; Micallef JP; Peruchon E; Ohanna F; Cristol JP; Rossi M; Leroux JL
    Calcif Tissue Int; 2005 Jun; 76(6):404-11. PubMed ID: 15812577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral changes in a transgenic mouse model for osteogenesis imperfecta.
    Cassella JP; Pereira R; Prockop DJ; Ali SY
    Br J Biomed Sci; 1996 Jun; 53(2):108-15. PubMed ID: 8757687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefzol level in the blood and tissues after its intramuscular and intravenous administration in patients with post-traumatic osteomyelitis].
    Gritsiĭ NP; Gaĭko GV; Galushko CV; Vakhnenko LM
    Ortop Travmatol Protez; 1989 Nov; (11):62-4. PubMed ID: 2630991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mass and turnover in fibromyalgia.
    Jacobsen S; Gam A; Egsmose C; Olsen M; Danneskiold-Samsøe B; Jensen GF
    J Rheumatol; 1993 May; 20(5):856-9. PubMed ID: 8336312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal bleeding in infancy: clinical, allergological, and microbiological examination.
    Arvola T; Ruuska T; Keränen J; Hyöty H; Salminen S; Isolauri E
    Pediatrics; 2006 Apr; 117(4):e760-8. PubMed ID: 16585287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of the correction of disorders of intestinal microcenosis in patients with acid-dependent diseases of the digestive apparatus].
    Tkachenko EI; Uspenskiĭ IuP; Avalueva EB; Zakharchenko MM; Baryshnikova NV
    Eksp Klin Gastroenterol; 2004; (6):52-6. PubMed ID: 16259442
    [No Abstract]   [Full Text] [Related]  

  • 15. Prompt diagnosis of suspected osteomyelitis by utilizing percutaneous bone culture.
    Caprioli R; Testa J; Cournoyer RW; Esposito FJ
    J Foot Surg; 1986; 25(4):263-9. PubMed ID: 3734330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
    Franchimont N; Putzeys V; Collette J; Vermeire S; Rutgeerts P; De Vos M; Van Gossum A; Franchimont D; Fiasse R; Pelckmans P; Malaise M; Belaiche J; Louis E
    Aliment Pharmacol Ther; 2004 Sep; 20(6):607-14. PubMed ID: 15352908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone regeneration and fracture healing. Experience with distraction osteogenesis model.
    Richards M; Goulet JA; Weiss JA; Waanders NA; Schaffler MB; Goldstein SA
    Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S191-204. PubMed ID: 9917639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaffold-based bone engineering by using genetically modified cells.
    Hutmacher DW; Garcia AJ
    Gene; 2005 Feb; 347(1):1-10. PubMed ID: 15777645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regional acceleratory phenomenon: an up-to-date rationale for bone decortication.
    Garg AK
    Dent Implantol Update; 1997 Aug; 8(8):63-4. PubMed ID: 9555235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of copper deficiency on growth and bone tissue formation].
    Smoliar VI; Biniashevskiĭ EV
    Vopr Pitan; 1988; (6):28-32. PubMed ID: 3232350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.